Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab - Villalobos Bollen, Matthias Americo; Czapiewski, Piotr; Reinmuth, Niels; Fischer, Jürgen; Andreas, Stefan; Kortsik, Cornelius; Serke, Monika; Wolf, Martin; Neuser, Petra; Reuss, Alexander; Schnabel, Philipp Albert; Thomas, Michael (Oncology letters, 2019)
Gesehen am 31.01.2020